| Brümmer, Jens C. (Analytical Services North GmbH 2007) |
n. a. |
University of Hamburg |
Germany |
| Brüning, Kai (DEKA Investment 200601) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Brünker, Hans-Günter (Direvo Industrial Biotech 200807– before amaxa 200501) |
n. a. |
Lonza (Group) |
Germany |
| Brüstle, Oliver (Univ Bonn 200809 Prof) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Brzózka, Krzysztof (Selvita 201511 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Selvita (Group) |
Poland |
| Brändle, Frank (Identxx GmbH 201104 Managing Director) |
Managing Director |
Identxx GmbH |
Germany |
| Brändle, Martin (Tecan 201201 Head Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Tecan (Group) |
Switzerland |
| Bräuchle, Christoph |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Bräuer, Uwe (Genius Venture Capital GmbH 201309 investment manager of Technologiefonds MV) |
Investment Manager |
Genius Venture Capital GmbH |
Germany |
| Bröcker, Rudolf (BRAIN 201507 Head Finance & Controlling) |
Controller (management) |
BRAIN (Group) |
Germany |
| Brönnimann, Christian (Dectris 201708 CEO) |
Chief Executive Officer (CEO) |
Dectris Ltd. (CH) |
Switzerland |
| Brönstrup, Mark (Helmholtz 201503 Prof + Head of Chemical Biology at HZI) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Buchanan, Iain (Noxxon 201009– interim CEO before Novexel CEO before Vertex Pharmaceuticals) |
Chief Executive Officer (CEO) |
Noxxon Pharma AG |
Germany |
| Buchberger, Bernd (MicroCoat Biotechnologie 201104 Managing Director) |
Managing Director |
MicroCoat Biotechnologie GmbH |
Germany |
| Buchbinder, Maurice (CryoTherapeutics 201607 CMO) |
Chief Medical Officer (CMO) |
CryoTherapeutics GmbH |
Germany |
| Buchenau, Udo |
n. a. |
Geneworx AG |
Germany |
| Buchholz, Bernd (Schleswig-Holstein (govt) 202001 Minister for Economic + Technology Affairs) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
| Buchholz, Mirko (PerioTrap Pharmaceuticals 201901– Managing Director) |
Managing Director |
PerioTrap Pharmaceuticals GmbH |
Germany |
| Buchholz, Stefan (Evonik 201203 Head Innovation Management at Advanced Intermediates Business Unit) |
n. a. |
Evonik (Group) |
Germany |
| Buckel, Peter (SuppreMol 2005–201304 CEO RETIRED 4/12 before atugen CEO + Xantos CEO + founder + Roche Mannheim) |
Chief Executive Officer (CEO) |
Baxter (Group) |
Germany |
| Buckland, Terry (Schauenburg 201308– Sales + Service Director at Markes Intl before Agilent + Varian + ABI) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Buckle, Isabelle (Institut Pasteur 201607 EVP Technology Transfer + Industrial Partnerships) |
IP Manager |
Institut Pasteur |
France |
| Buckman, Paul (Pathway Medical Technologies 201109 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
| Budd, David (Epistem 201603– CEO before Leica Biosystems + Siemens Healthcare Diagnostics + Bayer Diagnostics) |
Chief Executive Officer (CEO) |
Epistem (Group) |
United Kingdom (GB) |
| Buddensiek, Dirk (Baden-Württemberg (govt) 201707 Managing Director of MBG Baden-Württemberg) |
Managing Director |
Baden-Württemberg (govt region) |
Germany |
| Buecheler, Uwe (Boehringer 201901 Head of Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Buechner, Ton (Akzo Nobel 201511 CEO + Novartis 201602– Board Director PROPOSED) |
Chief Executive Officer (CEO) |
Akzo Nobel (Group) |
Netherlands |
| Buehler, Kevin (Novartis 201203 Head of Alcon division) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Buesa, Carlos (Oryzon Genomics SA 201404 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Oryzon Genomics (Group) |
Spain (España) |
| Bufe, Albrecht (Protectimmun 200808 Founder) |
Company Founder |
Protectimmun GmbH |
Germany |
| Buhl, Thomas (Global Bioenergies 201606 Head of Business Development) |
Business Development Manager / Strategy Manager |
Global Bioenergies (Group) |
France |
| Buhlmann, Carsten (Eppendorf 201409 International Product Manager) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Buhmann, Raymund (AptaIT GmbH 201707 Managing Director) |
Managing Director |
AptaIT GmbH |
Germany |
| Bui, Lynne A. (Khloris Biosciences 201904 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Khloris Biosciences Inc. |
United States (USA) |
| Builder, Stuart E. (Coherus 2010– Co-founder before at Genentech sind 1981) |
Company Founder |
Coherus BioSciences Inc. |
United States (USA) |
| Buis, Philipp (Coulter Partners 201703– Executive Director in Zurich before Jauch Assoc + Ward Howell/Neumann Intl) |
President/Director/Head Business Group/Unit/Division |
Coulter Partners (The Coulter Partnership Ltd.) |
Switzerland |
| Bujard, Hermann |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
| Bukowski, Nick (Schauenburg 201301 Business Development Manager at Almsco) |
Business Development Manager / Strategy Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Bulc, Ales (Global Bioenergies 201606 CEO of Global Bioenergies GmbH) |
Chief Executive Officer (CEO) |
Global Bioenergies (Group) |
Germany |
| Bulcke, Paul (Nestlé 201402 CEO) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
| Bull, David (Epigenomics 201703 Director of Marketing) |
Sales Manager / Marketing Manager |
Epigenomics (Group) |
United States (USA) |
| Buller, Fabian (Neurimmune 201804– CBO before JnJ Innovation + Covagen) |
Chief Business Officer (CBO) |
Neurimmune AG |
Switzerland |
| Buller, Ulrich (Fraunhofer 200811 Research Director) |
n. a. |
Fraunhofer (Group) |
Germany |
| Bullerdiek, Jörn |
n. a. |
University of Bremen |
Germany |
| Bullock, Heidi (Ingenuity 200603) |
n. a. |
Qiagen (Group) |
United States (USA) |
| Bulpin, Andrew (Millipore 200812 VP Upstream Bioprocess Business Unit) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Bulthuis, Roel (Inkef Capital 201811– Managing Director + Head Heathcare before Merck M Ventures + Fortis Bank + Devgen) |
Investment Manager |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
| Bumol, Thomas F. (Lilly 201708 SVP Biotechnology + Immunology Research) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Bundis, Florian (Peqlab 200809) |
n. a. |
Avantor (Group) |
Germany |
| Bunge, Dörte (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Bunger, Maureen (Lonza 201703 Product Manager ADME-Tox Solutions) |
Product Manager (personnel) |
Lonza (Group) |
Switzerland |
| Bungers, Simon (Labfolder 201509 Managing Director + Founder) |
Managing Director |
Labforward (Group) |
Germany |
| Buono, Stefano (Advanced Accelerator Applications 201402 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
France |
| Burckhardt, Andreas (MC Services 201304– Executive Director Corporate Broking before WestLB) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Burckhardt, Peter E. (Basel Inkubator 201603 CEO) |
Chief Executive Officer (CEO) |
Basel Inkubator (University of Basel + FHNW) |
Switzerland |
| Burdack, Christoph (Priaxon AG 201401 CEO) |
Chief Executive Officer (CEO) |
Priaxon AG |
Germany |
| Burema, Peter (NextPharma 202101 CEO) |
Chief Executive Officer (CEO) |
NextPharma (Group) |
United Kingdom (GB) |
| Burgaezy, Frank (Bruker 201201 President of Bruker AXS division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Burger, Anne (MedVenture Partners 2002– Director + Breath Therapeutics 201609– CFO + Curetis 201007–2012 CFO) |
Chief Executive Officer (CEO) |
MedVenture Partners GmbH |
Germany |
| Burger, Cyrill (PMOD Technologies 201907 CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Switzerland |
| Burger, Joachim (Univ Mainz 201211 Professor) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
| Burgermeister, Patrick (Apeiron 201101– Business Development Manager + BioMedPartners before Novartis) |
Business Development Manager / Strategy Manager |
Apeiron (Group) |
Austria |
| Burgess, Mike (BMS 201301– SVP Discovery Medicine + Clinical Pharmacology before Roche) |
Research & Development Manager |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Burgess, Rob (RayBiotech 201408 VP Business Development before Stem Cell Sciences) |
Business Development Manager / Strategy Manager |
RayBiotech Inc. |
United States (USA) |
| Burgstaller, Petra (BioM 202001 Senior Manager Start-ups + Funding) |
Cluster Manager |
Bavaria (govt region) |
Germany |
| Burian, Rainer C. (PAA Laboratories GmbH 201108 Managing Director) |
Managing Director |
General Electric (Group) |
Austria |
| Burkamp, Frank (Almac 201206 Senior Investigator) |
Researcher (industry) |
Almac (Group) |
United Kingdom (GB) |
| Burnet, Michael (Synovo GmbH 201109 Managing Director) |
Managing Director |
Synovo GmbH |
Germany |
| Burnet, Renate (Synovo GmbH 201710 Business Development) |
Business Development Manager / Strategy Manager |
Synovo GmbH |
Germany |
| Burns, Alasdair A. (Microstein LLC 201208 CEO) |
Chief Executive Officer (CEO) |
Microstein LLC |
United States (USA) |
| Burns, James W. (Jim) (Locana 201912– before Casebia Therapeutics + Sanofi-Genzyme + MassBio) |
Chief Executive Officer (CEO) |
Locanabio Inc. |
United States (USA) |
| Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO) |
Chief Executive Officer (CEO) |
Agenus (Group) |
Switzerland |
| Burns, Rowena (Manchester Science Partnerships 201208– CEO + 201807 Chair of Health Innovation Manchester) |
Cluster Manager |
Summit (Group) |
United Kingdom (GB) |
| Burns, William M. (Roche 200207–200904– CEO Pharma division) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
| Burow, Martin (GATC Biotech 201011– Head Commercial Operations LifeCodexx AG before Brahms AG Sales Manager Asia) |
Chief Commercial Officer (CCO) |
Eurofins (Group) |
Germany |
| Burrows, Jon (Oxford BioDynamics 202011 CEO formerly Expression Pathology + Ventana + Novartis + Chiron) |
Chief Executive Officer (CEO) |
Oxford BioDynamics (Group) |
United Kingdom (GB) |
| Busch, Andreas (Bayer 201201–201711 Head Global Drug Discovery at Bayer Healthcare LEFT 11/17) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Buschmann, Helmut (Savira Pharmaceuticals 201210 CSO) |
Chief Executive Officer (CEO) |
Savira Pharmaceuticals GmbH |
Austria |
| Bushell, Mike (Syngenta 200502) |
n. a. |
Syngenta (Group) |
Switzerland |
| Buss, Tony (MerLion –200707– CEO) |
Chief Executive Officer (CEO) |
MerLion (Group) |
Singapore |
| Busse, Falko (Bruker Corp 201805– President of Bruker BioSpin Group joined 2015 before Philips Healthcare) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Busse, Wolf-Dieter (Aerovance 200408– CEO before Bayer SVP Biotech) |
Chief Executive Officer (CEO) |
Aerovance Inc. |
United States (USA) |
| Butler, Lynn (Sirenade Pharmaceuticals 200407– CEO before Swentibold before Devgen) |
Chief Executive Officer (CEO) |
KeyNeurotek (Group) |
Germany |
| Butscheid, Yulia (Biognosys 201304– Head Strategy + Business Development before Creathor Venture + Novartis) |
Business Development Manager / Strategy Manager |
Biognosys AG |
Switzerland |
| Butscher, Philipp (Berliner Effektengesellschaft 201205 Associate at Ventegis Capital AG) |
n. a. |
Berliner Effektengesellschaft (Group) |
Germany |
| Buttar, Rabinder (ClinTec 1997– CEO + Founder) |
Chief Executive Officer (CEO) |
ClinTec (Group) |
United Kingdom (GB) |
| Butterfield, Stewart (Slack Technologies 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Salesforce (Group) |
United States (USA) |
| Buttkereit, Monika (Biotest 201308 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Creat (Group) |
Germany |
| Buyse, Chris (Fund+ 201610 Managing Partner before ThromboGenics 201203 CFO) |
Managing Partner |
Fund+ N.V. |
Belgium |
| Büchele, Wolfgang (Linde 201405 designated CEO + Board Chairman of Merck KGaA) |
Chief Executive Officer (CEO) |
Linde (Group) |
Germany |
| Büchler, Andrea (Lunaphore 201808 Finance + Business Development) |
Business Development Manager / Strategy Manager |
Lunaphore Technologies S.A. |
Switzerland |
| Byczynski, Michael (Eppendorf 200803) |
n. a. |
Eppendorf (Group) |
Germany |
| Bügling, Dieter (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Bühler, Markus (Technologiepark Heidelberg 201504 Startup Support Manager) |
n. a. |
Heidelberg (govt city) |
Germany |
| Bülow, Holger (Miltenyi 201901 Press Contact) |
Public Relations Manager / Investor Relations Manager |
Miltenyi Biotec (Group) |
Germany |
| Bülow, Sven (Eppendorf 201104 EVP Corporate Developm before Director Eppendorf Biochip Systems) |
Business Development Manager / Strategy Manager |
Eppendorf (Group) |
Germany |
| Büntemeyer, Heino (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
| Bünz, Alexander (Knauer 2006–2014 Managing Director LEFT 2015) |
Managing Director |
Knauer (Group) |
Germany |
| Bürger, Frank (Avida Group 200508 before WGZ-Bank) |
n. a. |
AVIDA Group (Dusseldorf) |
Germany |
| Bürger, Mario (GeSiM 200604 Managing Director) |
Managing Director |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 8 9 10 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
